stage IV adult diffuse small cleaved cell lymphoma
Showing 9976 - 10000 of >10,000
Healthy Trial in New Haven (PF-07304814, Placebo)
Completed
- Healthy
- PF-07304814
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 4, 2021
Acute Kidney Injury Due to Sepsis Trial (TIN816 70 mg lyophilisate powder, Placebo)
Not yet recruiting
- Acute Kidney Injury Due to Sepsis
- TIN816 70 mg lyophilisate powder
- Placebo
- (no location specified)
Aug 17, 2022
Psychological Resilience Trial in Ankara (Narrative Group Counseling, stress coping interviews)
Active, not recruiting
- Psychological Resilience
- Narrative Group Counseling
- stress coping interviews
-
Ankara, Çankaya, TurkeyGazi University
Nov 14, 2023
Anorexia Nervosa Trial in New York (Metabolic Diet)
Not yet recruiting
- Anorexia Nervosa
- Metabolic Diet
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 3, 2022
Bone Pain in Adults With Sickle Cell Disease
Recruiting
- Sickle Cell Disease
- +10 more
-
Sacramento, CaliforniaUC Davis Comprehensive Cancer Center
Nov 3, 2022
Celiac Disease Trial in Levanger (Endoscopy and biopsy)
Recruiting
- Celiac Disease
- Endoscopy and biopsy
-
Levanger, NorwayLevanger Hospital, Nord-Trøndelag Hospital Trust
Sep 16, 2022
Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Toronto (Durvalumab, Oleclumab)
Withdrawn
- Non Small Cell Lung Cancer
- Renal Cell Carcinoma
- Durvalumab
- Oleclumab
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 13, 2020
Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)
Recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
- Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
-
Atlanta, Georgia
- +2 more
Jul 15, 2022
Severe Asthma Trial in Japan (Biological: Experimental: Tezepelumab)
Completed
- Severe Asthma
- Biological: Experimental: Tezepelumab
-
Chuo-ku, Japan
- +4 more
May 9, 2022
Influenza Vaccination Trial in Singapore (Flublok Quadrivalent vaccine, Fluarix Quadrivalent vaccine, Flucelvax Quadrivalent
Not yet recruiting
- Influenza Vaccination
- Flublok Quadrivalent vaccine
- +2 more
-
Singapore, SingaporeNational Centre for Infectious Diseases (NCID)
Jul 26, 2022
Ovarian Cancer Recurrent Trial in Leiden (Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin)
Recruiting
- Ovarian Cancer Recurrent
- Tumor Infiltrating Lymphocytes (TIL)
- +3 more
-
Leiden, ZH, NetherlandsLeiden University Medical Center
Mar 30, 2021
COPD Trial in Sofia (CHF6001)
Recruiting
- Chronic Obstructive Pulmonary Disease
-
Sofia, BulgariaMC Comac Medical Ltd.
May 16, 2022
Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 21, 2022
Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 12, 2023
Healthy Volunteers Trial in London (BGB149, Placebo)
Completed
- Healthy Volunteers
- BGB149
- Placebo
-
London, Harrow, Middlesex, United KingdomParexel Northwick Park
Mar 1, 2022
POH Trial in San Diego (PiQo4 Laser System)
Recruiting
- POH
- PiQo4 Laser System
-
San Diego, CaliforniaCosmetic Laser Dermatology, A West Dermatology Company
Mar 15, 2022
Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in Columbus (Educational
Not yet recruiting
- Breast Cancer
- +20 more
- Educational Intervention
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 6, 2022
Small Bowel Obstruction Trial in Pesaro (Laparoscopic approach to small bowel obstrcuction)
Enrolling by invitation
- Small Bowel Obstruction
- Laparoscopic approach to small bowel obstrcuction
-
Pesaro, Pesaro-Urbino, ItalyDepartment of General Surgery, San Salvatore Hospital , AST Pesa
Apr 21, 2023
Asthma Trial in Manchester (Placebo 152a, Placebo 134a)
Recruiting
- Asthma
- Placebo 152a
- Placebo 134a
-
Manchester, United KingdomMedicine Evaluation Unit Limited
Aug 17, 2022